Theravance Biopharma, Inc. · NASDAQ:TBPH
Winningham Rick E disposed of 1,726,989 Theravance Biopharma, Inc. shares (Form 4)
Traded Sep 23, 2026 · Filed Sep 24, 2026
On Sep 23, 2026, Winningham Rick E (Director, CHIEF EXECUTIVE OFFICER) disposed of 1,726,989 Theravance Biopharma, Inc. shares, leaving 0 shares. Filed Sep 24, 2026 (Form 4).
- Disposed of
- 1,726,989 shares
- Holding after
- 0 shares (held indirectly)
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 23, 2026 | Ordinary Shares | Disposition | 1,382,272 | 228,750 | Direct | |
| Sep 23, 2026 | Ordinary Shares | Disposition | 151,875 | 76,875 | Direct | |
| Sep 23, 2026 | Ordinary Shares | Disposition | 76,875 | 0 | Direct | |
| Sep 23, 2026 | Ordinary Shares | Disposition | 23,400 | 0 | Indirect | |
| Sep 23, 2026 | Ordinary Shares | Disposition | 92,567 | 0 | Indirect |
Source
Related
- Theravance Biopharma, Inc.
- Winningham Rick E
- Theravance Biopharma, Inc. shareholders
- Form 4 · Winningham Rick E · Aug 24, 2026
- Form 4 · Winningham Rick E · May 22, 2026
- Form 4 · Winningham Rick E · Apr 3, 2026
- Form 4 · Weiss Asset Management LP · Sep 28, 2026
- Schedule 13D/A · Weiss Asset Management LP · Sep 25, 2026
- Form 4 · Pakianathan Deepika · Sep 24, 2026
- Form 4 · O'Connor Donal · Sep 24, 2026
- Form 4 · Mitchell Dean J · Sep 24, 2026